Regeneron hopes US will greenlight COVID-19 antibody drug soon
The treatment, which was given to President Trump, is under review by the US Food and Drug Administration.
External Content
| Source | RSS or Atom Feed |
| Feed Location | https://www.aljazeera.com/xml/rss/all.xml |
| Feed Title | Al Jazeera – Breaking News, World News and Video from Al Jazeera |
| Feed Link | https://www.aljazeera.com/ |
| Feed Copyright | © 2026 Al Jazeera Media Network |
| Reply | 0 comments |